OpenLegislation

Division 1.2.4

United Kingdom

Original text. Later amendments are not shown.

Macrolides

Pharmacologically active substance(s)Marker residueAnimal speciesMRLsTarget tissuesOther provisions
SpiramycinSum of spiramycin and neospiramycinBovine200 μg/kgMuscle
300 μg/kgFat
300 μg/kgLiver
300 μg/kgKidney
200 μg/kgMilk
Chicken200 μg/kgMuscle
300 μg/kgSkin and fat
400 μg/kgLiver
TilmicosinTilmicosinBovine, ovine, porcine50 μg/kgMuscle
50 μg/kgFat
1 000 μg/kgLiver
1 000 μg/kgKidney
Ovine50 μg/kgMilk
Chicken75 μg/kgMuscleNot for use in animals from which eggs are produced for human consumption
75 μg/kgSkin and fat
1 000 μg/kgLiver
250 μg/kgKidney
TylosinTylosin ABovine100 μg/kgMuscle
100 μg/kgFat
100 μg/kgLiver
100 μg/kgKidney
50 μg/kgMilk
Porcine100 μg/kgMuscle
100 μg/kgSkin and fat
100 μg/kgLiver
100 μg/kgKidney
Poultry100 μg/kgMuscle
Not for use in hens producing eggs for human consumption100 μg/kgSkin and fat
100 μg/kgLiver
100 μg/kgKidney